1. Home
  2. SHOO vs HAE Comparison

SHOO vs HAE Comparison

Compare SHOO & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$36.53

Market Cap

3.3B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$57.68

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOO
HAE
Founded
1990
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.9B
IPO Year
1993
1991

Fundamental Metrics

Financial Performance
Metric
SHOO
HAE
Price
$36.53
$57.68
Analyst Decision
Buy
Buy
Analyst Count
8
9
Target Price
$42.75
$86.00
AVG Volume (30 Days)
1.6M
1.0M
Earning Date
02-25-2026
02-05-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
43.84
EPS
0.78
3.65
Revenue
$2,362,727,000.00
$1,318,275,000.00
Revenue This Year
$13.06
N/A
Revenue Next Year
$12.67
$5.86
P/E Ratio
$45.72
$16.25
Revenue Growth
6.41
N/A
52 Week Low
$19.05
$47.32
52 Week High
$46.88
$87.32

Technical Indicators

Market Signals
Indicator
SHOO
HAE
Relative Strength Index (RSI) 33.10 16.29
Support Level $33.89 $64.75
Resistance Level $46.88 $67.63
Average True Range (ATR) 2.13 2.44
MACD -1.16 -0.89
Stochastic Oscillator 20.63 3.90

Price Performance

Historical Comparison
SHOO
HAE

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: